Yes. Influenza can cause loss of taste and smell, though it does so less often than viruses like SARS-CoV-2, and by different mechanisms. Estimates for influenza put chemosensory loss at roughly 10 to 30 percent of confirmed cases, depending on the strain, the study, and whether loss is measured subjectively or by formal testing. Most people recover within days to a few weeks, but a minority have persistent dysfunction that outlasts other symptoms by months.
The distinction matters because the flu and COVID-19 overlap heavily in symptoms, and smell loss has been treated as a shortcut for distinguishing them. It is not a reliable one. Influenza can produce genuine olfactory and gustatory deficits, and the pathway it uses is worth understanding before you assign blame to one virus or the other.
The airway route to smell loss
Smell depends on a small patch of olfactory sensory neurons in the roof of the nasal cavity. These neurons extend cilia into a layer of mucus, where odorant molecules bind to receptors and trigger a signal that travels along the olfactory nerve to the olfactory bulb and then to the cortex. Anything that blocks odorants from reaching the receptors, damages the neurons, or disrupts that wiring produces smell loss.
Influenza attacks the respiratory epithelium first. Infection and the immune response it triggers cause swelling of the nasal mucosa, increased mucus production, and shedding of epithelial cells. The nasal passages narrow, and the mucus layer over the olfactory cleft thickens. Odorant molecules physically cannot reach the receptors in sufficient concentration. This is called conductive loss, and it is the dominant mechanism in flu. In practical terms, the nose is blocked and coated, and smell signals are muffled or absent.
There is a second, deeper route. Influenza can infect cells in the olfactory epithelium, and inflammatory cytokines released during the immune response can damage the olfactory epithelium and, in severe cases, the olfactory bulb. Animal models of influenza infection have shown olfactory neuron death and bulb inflammation. Human data are thinner, but the pattern is consistent with what clinicians see: smell loss that persists after congestion clears, which points to neural or inflammatory damage rather than simple obstruction.
Taste loss in flu is mostly secondary. True taste buds detect sweet, salty, sour, bitter, and umami. What most people call taste is largely retronasal smell, the aroma of food traveling up the back of the throat. When smell is impaired, food tastes bland. Genuine taste bud dysfunction can occur through direct inflammation of the oral mucosa, but it is less common. The practical result is that flu patients often report "loss of taste" when the primary deficit is olfactory.
How common it is, and how flu compares
Numbers vary widely by method. Self-reported smell loss in influenza patients clusters in the range of 10 to 30 percent. Objective testing, which asks people to identify odors rather than recall whether they can smell, tends to find higher rates of measurable dysfunction than self-report suggests, because people adapt to gradual loss. During the 2009 H1N1 pandemic, several studies reported smell and taste complaints in a minority of confirmed cases, generally under 30 percent.
The comparison with SARS-CoV-2 is where the data become useful. COVID-19 is associated with smell loss in a much higher proportion of cases, with estimates frequently cited in the 40 to 60 percent range for earlier variants. The mechanism differs in an important way: SARS-CoV-2 does not appear to infect olfactory sensory neurons directly in most cases. Instead it infects supporting cells in the olfactory epithelium, triggering inflammation that disrupts neuron function while the neurons themselves survive. Influenza more directly involves the epithelium and, in severe cases, the bulb.
| Feature | Influenza | SARS-CoV-2 | Common cold (rhinovirus) | Allergic rhinitis |
|---|---|---|---|---|
| Typical smell loss rate | 10–30% | 40–60% (variant-dependent) | Low, mostly conductive | Low, conductive |
| Main mechanism | Mucosal swelling, epithelial inflammation | Supporting-cell infection, inflammation | Congestion and mucus | Congestion and mucus |
| Onset relative to other symptoms | With or after congestion | Often early, sometimes isolated | With congestion | With congestion |
| Typical recovery | Days to weeks | Days to weeks, minority months | Days | With allergen removal |
| True taste bud involvement | Uncommon | Uncommon | Rare | Rare |
The table is a guide, not a diagnostic test. Overlap is substantial, and a single symptom cannot separate the viruses. The counterintuitive detail is that the virus most famous for smell loss, SARS-CoV-2, is not the one that most directly damages olfactory neurons. Influenza is more likely to injure the epithelium itself, which is part of why severe flu can leave a longer inflammatory footprint even when the overall rate of smell loss is lower.
Timing: when loss appears and when it resolves
The time course helps distinguish flu-related chemosensory loss from other causes and sets expectations for recovery.
| Phase | Typical timing | What is happening |
|---|---|---|
| Exposure and incubation | 1–4 days after exposure | Virus replicates in respiratory epithelium |
| Congestion and smell loss | Days 2–5 of illness | Mucosal swelling and mucus block odorant access |
| Peak inflammatory phase | Days 3–7 | Cytokine release, epithelial shedding |
| Early recovery | Days 7–14 | Congestion subsides, smell begins to return |
| Prolonged dysfunction | Beyond 2–4 weeks | Persistent epithelial or neural inflammation |
| Chronic loss | Beyond 3 months | Less common; warrants evaluation |
Most flu-related smell loss resolves as congestion does, within one to two weeks. A subset of patients report dysfunction lasting four weeks or more. Beyond three months, the loss is considered persistent and deserves clinical attention, not because flu cannot cause it, but because other causes need to be excluded and because persistent loss has its own management pathway.
Taste typically returns in parallel with smell, since retronasal olfaction drives most of what people perceive as flavor. If taste remains genuinely impaired after smell recovers, that suggests a separate problem, such as oral mucosal inflammation or a medication effect.
Edge cases and what changes the picture
Age matters. Older adults have fewer olfactory sensory neurons and a thinner olfactory epithelium at baseline, so any insult produces a larger functional deficit and slower recovery. Children tend to recover faster, though they may not report smell loss unless asked directly.
Severity of flu correlates with chemosensory risk. Mild cases produce mainly conductive loss from congestion. Severe cases, especially those requiring hospitalization, involve more intense inflammation and a higher likelihood of epithelial damage and prolonged dysfunction.
Pregnancy, smoking, and pre-existing olfactory dysfunction all shift the baseline. A smoker with chronic mild smell loss may not notice flu-related decline until it is substantial. Someone with prior COVID-19-related smell loss may have a different recovery trajectory after flu, though the interaction is not well characterized.
A professional caveat: many "flu" diagnoses are clinical and never laboratory-confirmed. Studies that rely on self-reported flu and self-reported smell loss are subject to recall bias and misclassification. Some of the smell loss attributed to flu in everyday experience is actually COVID-19, rhinovirus, or a coinfection. The mechanistic story is solid; the epidemiological precision is not.
Misconceptions worth correcting
The most common misconception is that loss of smell or taste reliably indicates COVID-19. It does not. Influenza, rhinovirus, parainfluenza, and other respiratory viruses can all produce it, and the overlap is large enough that symptom-based triage is unreliable. Testing is the only way to distinguish them.
A second misconception is that taste loss means taste bud damage. Most reported taste loss is olfactory. If you can still detect sweet, salty, sour, bitter, and umami when your nose is pinched, your taste buds are working and the problem is smell.
A third is that smell loss from flu is always temporary. Most cases resolve, but a meaningful minority persist beyond a month, and a smaller group beyond three months. Dismissing persistent loss as something that will pass can delay evaluation.
A fourth is that smell training is a gimmick. Structured olfactory training, repeated exposure to a set of distinct odors over weeks to months, has evidence for improving recovery in post-viral smell loss, including after influenza. It is low-risk and reasonable to start early.
Practical actions and thresholds
If you have flu symptoms and notice smell or taste changes, the first step is confirming what you have. A home antigen test or a clinic test for influenza and SARS-CoV-2 clarifies the cause and informs isolation decisions. Do not assume the virus based on the symptom.
Seek urgent care for trouble breathing, chest pain, confusion, severe dehydration, or a fever that returns after improving. These are flu red flags, not smell-related ones. See a clinician if smell or taste loss persists beyond four weeks, or if it is accompanied by facial pain, bloody discharge, or vision changes. Start olfactory training early if loss persists past the acute phase. Use four distinct odors, sniff each for about 20 seconds twice daily, and track progress weekly. Avoid self-prescribed steroid nasal sprays without guidance; they are not a proven standalone treatment for post-viral smell loss. Keep a simple symptom log with dates, since the timing of onset and recovery is clinically useful. Do not use smell loss as a reason to skip testing or to assume immunity to one virus over another.
A reasonable threshold for action: if smell has not begun to improve by two weeks after congestion clears, or if it is unchanged at four weeks, get evaluated. Earlier evaluation is warranted if loss is complete rather than partial, or if there is unilateral loss, which points away from a viral cause.
What the evidence cannot tell you
The mechanisms are well supported, but the precise rates, the contribution of direct viral injury versus immune-mediated damage, and the long-term prognosis after influenza are less certain than headlines suggest. Much of the mechanistic evidence comes from animal models and from COVID-19 research, and extrapolating to flu requires caution. Human biopsy data on influenza-related olfactory damage are limited.
There is also no reliable way to predict individual recovery from symptom patterns alone. Age, severity, and baseline function help, but they do not determine outcome. A patient with mild flu and complete smell loss can recover fully; a patient with severe flu and partial loss can have persistent dysfunction. The honest position is that most people recover, a minority do not, and persistent loss should be evaluated rather than assumed benign.
The practical takeaway is straightforward. Influenza can cause loss of taste and smell, primarily through nasal inflammation and epithelial damage that blocks odorant access and disrupts olfactory signaling. It is less common than with SARS-CoV-2 but frequent enough that the symptom cannot distinguish the two. Most cases resolve within weeks. Persistent loss beyond a month deserves clinical attention, and olfactory training is a reasonable early intervention with low risk and some evidence of benefit.